Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels

Journal of Clinical Investigation

Volumn 118, Issue 7, 2008, Pages 2620-2628

  Chen, Wei Min ^a,b   Erdos, Michael R ^c   Jackson, Anne U ^d   Saxena, Richa ^e   Sanna, Serena ^d,f   Silver, Kristi D ^g   Timpson, Nicholas J ^h   Hansen, Torben ⁱ   Orrù, Marco ^f   Piras, Maria Grazia ^f   Bonnycastle, Lori L ^c   Wilier, Cristen J ^d   Lyssenko, Valeriya ^j   Shen, Haiqing ^g   Kuusisto, Johanna ^k   Ebrahim, Shah ^l   Sestu, Natascia ^m   Duren, William L ^d   Spada, Maria Cristina ^f   Stringham, Heather M ^d   Scott, Laura J ^d   Olla, Nazario ^f   Swift, Amy J ^c   Najjar, Samer ^m   Mitchell, Braxton D ^g   Lawlor, Debbie A ^h   Smith, George Davey ^h   Ben Shlomo, Yoav ^h   Andersen, Gitte ⁱ   Borch Johnsen, Knut ^i,n,o   Jørgensen, Torben ⁿ   Saramies, Jouko ^p   Valle, Timo T ^q,r   Buchanan, Thomas A ^s,t   Shuldiner, Alan R ^g   Lakatta, Edward ^m   Bergman, Richard N ^t   Uda, Manuela ^f   Tuomilehto, Jaakko ^q,r,u   Pedersen, Oluf ^i,o   Cao, Antonio ^f   Groop, Leif ^j   Mohlke, Karen L ^v   Laakso, Markku ^k   Schlessinger, David ^m   Collins, Francis S ^c   Altshuler, David ^e   Abecasis, Gonçalo R ^d   Boehnke, Michael ^d   Scuteri, Angelo ^w,x   Watanabe, Richard M ^t   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f CNR   (Italy)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

ⁱ STENO DIABETES CENTER   (Denmark)

^j LUND UNIVERSITY   (Sweden)

^k KUOPIO UNIVERSITY HOSPITAL   (Finland)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m NATIONAL INSTITUTE ON AGING   (United States)

ⁿ GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^o AARHUS UNIVERSITY   (Denmark)

^p Savitaipale Health Center   (Finland)

^q NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^r UNIVERSITY OF HELSINKI   (Finland)

^s Division of Endocrinology   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^v UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^w NATIONAL INSTITUTE ON AGING   (United States)

^x Istituto Nazionale di Ricovero e Cura per Anziani   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLUCOSE 6 PHOSPHATASE;

ABCB11 GENE; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; G6PC2 GENE; GENE; GENE EXPRESSION; GENETIC VARIABILITY; GENOME ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; LIVER; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GLUCOSE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FINLAND; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; GLUCOSE-6-PHOSPHATASE; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 46749100599     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JC134566     Document Type: Article

References (68)

1. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
2. DeFronzo, R.A. 1987. The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:667-687.
3. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
4. [No authors listed]. 1985. Diabetes Mellitus: Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 727:1-113.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1183-1197.
6. DeFronzo, R.A., and Ferrannini, E. 1991. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:173-194.
7. Xiang, A.H., et al. 2006. Coordinate changes in plasma glucose and pancreatic β-cell function in Latino women at high risk for type 2 diabetes. Diabetes. 55:1074-1079.
8. Mason, C.C., Hanson, R.L., and Knowler, W.C. 2007. Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes. 56:2054-2061.
9. Rich, S.S. 1990. Mapping genes in diabetes. Diabetes. 39:1315-1319.
10. Ghosh, S., and Schork, N.J. 1996. Genetic analysis of NIDDM: the study of quantitative traits. Diabetes. 45:1-14.
11. Diabetes Prevention Program Research Group. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:393-403.
12. Tuomilehto, J., et al. 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:1343-1350.
13. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, et al. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 316:1331-1336.
14. Scott, L.J., et al. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 316:1341-1345.
15. Zeggini, E., et al. 2007. Replication of genome-wide association signals in U.K. samples reveals risk loci for type 2 diabetes. Science. 316:1336-1341.
16. Sladek, R., et al. 2007. A genome-wide association study identified novel risk loci for type 2 diabetes. Nature. 445:881-885.
17. Steinthorsdottir, V., et al. 2007. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39:770-775.
18. Zeggini, E., et al. 2008. Meta-analysis of genomewide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40:638-645.
19. Beaty, T.H., and Fajans, S.S. 1982. Estimating genetic and non-genetic components of variance for fasting glucose levels in pedigrees ascertained through non-insulin dependent diabetes. Ann. Hum. Genet. 46:355-362.
20. Boehnke, M., Moll, P.P., Kottke, B.A., and Weidman, W.H. 1987. Partitioning the variability of fasting plasma glucose levels in pedigrees. Am. J. Epidemiol. 125:679-689.
21. Sakul, H., et al. 1997. Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am. J. Hum. Genet. 60:651-656.
22. Watanabe, R.M., et al. 1999. Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Hum. Hered. 49:159-168.
23. Henkin, L., et al. 2003. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS family study design and methods. Ann. Epidemiol. 13:211-217.
24. Pilia, G., et al. 2006. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2:e132.
25. Weedon, M.N., et al. 2006. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: Association in six studies and population-genetics analyses. Am. J. Hum. Genet. 79:991-1001.
26. Valle, T., et al. 1998. Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care. 21:949-958.
27. Silander, K., et al. 2004. A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes. 53:821-829.
28. Scuteri, A., et al. 2007. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3:1200-1210.
29. Hsueh, W.-C., et al. 2001. Genome-wide scan of obesity in the Old Order Amish. J. Clin. Endocrinol. Metab. 86:1199-1205.
30. Sorkin, J., et al. 2005. Exploring the genetics of longevity in the Old Order Amish. Mech. Ageing Dev. 126:347-350.
31. Post, W., et al. 2007. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the Old Order Amish. Hum. Hered. 64:214-219.
32. The Caerphilly and Speedwell Collaborative Group. 1984. Caerphilly and Speedwell collaborative heart disease studies. J. Epidemiol. Community Health. 38:259-262.
33. Lawlor, D., Bedford, C., Taylor, M., and Ebrahim, S. 2003. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J. Epidemiol. Community Health. 57:134-140.
34. Jørgensen, M.E., et al. 2003. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int. J. Obes. Relat. Metab. Disord. 27:1507-1515.
35. Glümer, C., Jørgensen, T., Borch-Johnsen, K., and Inter99 study. 2003. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care. 26:2335-2340.
36. Petrolonis, A.J., et al. 2004. Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP). J. Biol. Chem. 279:13976-13983.
37. Shieh, J.-J., Pan, C.-J., Mansfield, B.C., and Chou, J.Y. 2005. In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity. Diabetologia. 48:1851-1859.
38. van Mil, S.W.C., et al. 2004. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology. 127:379-384.
39. Lang, C., et al. 2007. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 assocaited with drug-induced liver injury. Pharmacogenet. Genomics. 17:47-60.
40. Devlin, B., and Roeder, K. 1999. Genomic control for association studies. Biometrics. 55:997-1004.
41. Funk, C., Ponelle, C., Scheuermann, G., and Pantze, M. 2001. Cholestatic potential of troglitazone as a possible factor contributing to troglitazoneinduced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol. Pharmacol. 59:627-635.
42. Staels, B., and Kuipers, F. 2007. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs. 67:1383-1392.
43. Mukherjee, R., Wagar, D., Stephens, T.A., Lee-Chan, E., and Singh, B. 2005. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes. J. Immunol. 174:5306-5315.
44. Wang, Y., et al. 2007. Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia. 50:774-778.
45. Arden, S.D., et al. 1999. Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase cataliytic subunit-related protein. Diabetes. 48:531-542.
46. Shieh, J.-J., Pan, C.-J., Mansfield, B.C., and Chou, J.Y. 2004. The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glyco-protein embedded in the endoplasmic reticulum membrane. FEBS Lett. 562:160-164.
47. Dogra, R.S., et al. 2006. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia. 49:953-957.
48. Pan, C.-J., Lei, K.-J., Annabi, B., Hemrika, W., and Chou, J.Y. 1998. Transmembrane topology of glucose-6-phosphatase. J. Biol. Chem. 273:6144-6148.
49. Khan, A., et al. 1990. Glucose cycling in islets from healthy and diabetic rats. Diabetes. 39:456-459.
50. Khan, A., et al. 1989. Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse. J. Biol. Chem. 264:9732- 9733.
51. Khan, A., et al. 1990. Glucose cycling is markedly enhanced in pancreatic islets of obese hyperglycemic mice. Endocrinology. 126:2413-2416.
52. Vaulont, S., Vasseur-Cognet, M., and Kahn, A. 2000. Glucose regulation of gene transcription. J. Biol. Chem. 275:31555-31558.
53. Stone, L.M., Kahn, S.E., Deeb, S.S., Fujimoto, W.Y., and Porte, D., Jr. 1994. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Diabetes Care. 17:1480-1483.
54. Stone, L.M., Kahn, S.E., Fujimoto, W.Y., Deeb, S.S., and Porte, D., Jr. 1996. A variation at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes. 45:422-428.
55. Rose, C.S., et al. 2005. A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes. 54:3026-3031.
56. Weedon, M.N., et al. 2005. Genetic regulation of birth weight and fasting glucose by a common polymophism in the islet promoter of the glucokinase gene. Diabetes. 54:576-581.
57. Malaisse, W.J., Malaisse-Lagae, F., Davies, D.R., Vandercammen, A., and Van Schaftingen, E. 1990. Regulation of glucokinase by a fructose-1-phosphate- sensitive protein in pancreatic islets. Eur. J. Biochem. 190:539-545.
58. Frayling, T.M., et al. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 316:889-894.
59. Sanna, S., et al. 2008. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat. Genet. 40:198-203.
60. Willer, C.J., et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40:161-169.
61. Li, Y., Willer, C.J., Ding, J., Scheet, P., and Abecasis, G.R. 2008. Markov model for rapid haplotyping and genotype imputation in genome wide studies. Nat. Genet. In press.
62. [Anonymous]. 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. WHO. Geneva, Switzerland. www.diabetes.com.au/pdf/ who_report.pdf.
63. Livak, K.J. 1999. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal. 14:143-149.
64. Burdick, J.T., Chen, W.M., Abecasis, G.R., and Cheung, V.G. 2006. In silico method for inferring genotypes in pedigrees. Nat. Genet. 38:1002-1004.
65. Chen, W.-M., and Abecasis, G.R. 2007. Family based association tests for genome wide association scans. Am. J. Hum. Genet. 81:913-926.
66. D'Orazio, P., et al. 2005. Approved IFCC recommendations on reporting results for blood glucose (abbreviated). Clin. Chem. 51:1573-1576.
67. Blangero, J., and Almasy, L. 1997. Multipoint oligogenic linkage analysis of quantitative traits. Genet. Epidemiol. 14:959-964.
68. Almasy, L., and Blangero, J. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62:1198-1211.